Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Mostrar más
Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune diseases, and oncology Enrolling patients in the...
Prioritize clinical and preclinical development on type 1 diabetes (UP421 and SC451), B-cell mediated autoimmune diseases (SC291), refractory B-cell malignancies (SC262), and the fusogen platform...
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence PR Newswire CAMBRIDGE, Masss. and LONDON, Oct...
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors PR Newswire CAMBRIDGE, Mass., Oct. 3, 2024 CAMBRIDGE, Mass., Oct. 3, 2024 /PRNewswire/ -- Invaio Sciences, a Flagship...
SEATTLE, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.71 | -22.6837060703 | 3.13 | 3.18 | 2.415 | 1776886 | 2.79164143 | CS |
| 4 | -1.7 | -41.2621359223 | 4.12 | 4.23 | 2.415 | 1401288 | 3.32965047 | CS |
| 12 | -3.33 | -57.9130434783 | 5.75 | 6.34 | 2.415 | 1364271 | 4.15466155 | CS |
| 26 | -6.52 | -72.9306487696 | 8.94 | 9.49 | 2.415 | 1566341 | 5.33854119 | CS |
| 52 | -1.38 | -36.3157894737 | 3.8 | 12 | 2.415 | 2055940 | 6.42110222 | CS |
| 156 | -19.58 | -89 | 22 | 22.12 | 2.415 | 1485983 | 6.3598449 | CS |
| 260 | -35.48 | -93.6147757256 | 37.9 | 44.6 | 2.415 | 1312139 | 8.24099959 | CS |
Monksdream
4 semanas hace
Monksdream
2 meses hace
Monksdream
4 meses hace
Monksdream
4 meses hace
Monksdream
9 meses hace
Monksdream
10 meses hace
Moneymaker77777
2 años hace
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
